Next Article in Journal
Synthesis, Characterization, and Cytotoxicity of Some New 5-Aminopyrazole and Pyrazolo[1,5-a]pyrimidine Derivatives
Previous Article in Journal
Hyaluronan–Itaconic Acid–Glutaraldehyde Films for Biomedical Applications: Preliminary Studies
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Article

Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship

HTA Unit, Regional Health Service, ESTAR, via San Salvi 12, 50135 Firenze, Italy.
Sci. Pharm. 2016, 84(1), 73-79; https://doi.org/10.3797/scipharm.1506-03
Received: 11 June 2015 / Accepted: 27 August 2015 / Published: 27 August 2015
In managing drug prices at the national level, price-volume agreements are a tool aimed at ensuring sustainability in cases where the drug price is high and the population is large. These agreements in fact determine a progressive price reduction as more and more patients are treated. Price decays in this context generally have a purely empirical nature, but a theoretical basis would be needed.
The present paper describes a simple model that manages price-volume agreements. Two real examples (ranibizumab for macular degeneration and sofosbuvir for hepatitis C) are analysed in detail. The objective of our analysis was to identify some objective criteria to rationally guide these agreements and to convert these criteria into explicit quantitative rules.
Keywords: Price-volume agreements; Sofosbuvir; Ranibizumab Price-volume agreements; Sofosbuvir; Ranibizumab
MDPI and ACS Style

MESSORI, A. Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship. Sci. Pharm. 2016, 84, 73-79. https://doi.org/10.3797/scipharm.1506-03

AMA Style

MESSORI A. Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship. Scientia Pharmaceutica. 2016; 84(1):73-79. https://doi.org/10.3797/scipharm.1506-03

Chicago/Turabian Style

MESSORI, Andrea. 2016. "Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship" Scientia Pharmaceutica 84, no. 1: 73-79. https://doi.org/10.3797/scipharm.1506-03

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop